STOCK TITAN

Herborium® Targets $6.5 Billion French Amazon Market for its unique AcnEase® Botanical Therapeutic® and its New Skin Protein Bar

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Herborium Group, Inc. (HBRM) announced that it expects sales of its proprietary AcnEase® skin stem cell products and Skin Protein Bar to commence on Amazon France by Fall 2021. The online skincare market in France surged 123% in 2020, with body care growing 225%. Following this launch, Herborium plans to penetrate the second-largest French online retailer, cdiscount.com, which had revenues of $2.2 billion in 2020. Additionally, an updated website is set for deployment by the end of September 2021, aligning with new OTC regulations.

Positive
  • Expected launch of AcnEase and Skin Protein Bar on Amazon France could leverage the rapidly growing skincare market, projected growth of 123% in 2020.
  • Plans for expansion to cdiscount.com, increasing market penetration in France.
  • Website upgrade anticipated by September 2021 to align with OTC regulations, improving investor confidence.
Negative
  • None.

Insights

Analyzing...

Revenues Expected to Commence in 4th Quarter of 2021.

Houston , Aug. 23, 2021 (GLOBE NEWSWIRE) -- Houston, Texas, 08/23/2021. Herborium Group, Inc.  (OTC Pink: HBRM),  a Botanical Therapeutics Company and the provider of unique, all botanical medicinal products with a strong records of efficacy and safety, (Botanical Therapeutics®),  announced today that it expects to commence the sales of its proprietary Botanical Therapeutic® AcnEase®, its line of skin stem cell products, as well as its new Skin Protein Bar on French Amazon as soon as in a Fall of 2021. 

Amazon France is the largest on-line retailer in France with 2020 revenues reaching $6.5 billion. In addition, on-line sales of skincare products in France skyrocket 123% in 2020, while on-line sales of body care grew an astounding 225%. Proprietary AcnEase formula has been proven effective for both face and body acne symptoms.

After establishing itself on Amazon France Herborium plans expanding its French market penetration by targeting the second largest on-line French retailer www. c.discount.com that commanded $2.2 billion in revenues for 2020.   

To secure further growth of the Company we are presently updating our Herborium website www.herborium.com . The new updated and upgraded website is expected to be redeployed by the end of September 2021.

Lastly, Herborium is working on a number of corporate governance items that we believe will keep the Company in compliance with new OTC regulations and new brokerage organizations requirements.  These activities will allow the Company to return to and maintain the highest tier of current information and will  benefits both investors and the company’ position on the market.  

About Herborium Group, Inc.
Herborium Group, Inc., a botanical therapeutics company that develops, license and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements). The Company uses clinical validation and a proactive regulatory strategy based on the FDA Guidance for Industry: Botanical Drug Products to establish and maintain a differential advantage. Herborium has secured a pipeline of botanical ingredients based products in the areas of dermatological needs, wellness and energy, women’s health and selected sexual disorders and has built the versatile, technologically advanced, interactive content platform to support consumer needs.  Herborium Group sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce. For more information, please visit www.herborium.com, www.acnease.comwww.acnease.fr and www.acneasesp.com

Safe Harbor Statement: This release contains forward-looking statements with respect to the results of operations and business of Herborium Group, Inc., which involves risks and uncertainties. The Company's actual future results could materially differ from those discussed.  The Company intends that such statements about the Company's future expectations, including future revenues and earnings, and all other forward looking statements be subject to the "Safe Harbors" provision of the Private Securities Litigation Reform Act of 1995.

Attachment


FAQ

When will Herborium Group's products be available for sale?

Herborium Group expects to commence sales of its products on Amazon France by Fall 2021.

What is the expected impact of Herborium's product launch on the skincare market?

Herborium is entering a skincare market in France that grew 123% in 2020, which indicates significant growth potential.

Which online retailers is Herborium targeting for product sales?

After launching on Amazon France, Herborium plans to expand to cdiscount.com, the second-largest online retailer in France.

What is the significance of Herborium's website update?

The website update, expected by the end of September 2021, aims to improve compliance with new OTC regulations and enhance investor relations.
Herborium Group

OTC:HBRM

HBRM Rankings

HBRM Latest News

HBRM Stock Data

1.09M
10.92B
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
Fort Lee